Fmoc-Arg(Mtr)-OPfp

Fmoc-Arg(Mtr)-OPfp is an Fmoc-protected arginine derivative bearing an Mtr (4-methoxy-2,3,6-trimethylbenzenesulfonyl) side-chain guanidinium protection and an OPfp ester at the carboxylate, providing a chiral amino acid building block configured for peptide coupling chemistry. The molecule contains the α-amino group masked by the base-labile Fmoc carbamate, a stereogenic center typical of L-arginine-derived scaffolds, and a guanidinium functionality that is sterically and electronically moderated by Mtr to reduce undesired side reactions during assembly. The OPfp leaving group (pentafluorophenyl ester) activates the carboxylate toward amide bond formation under peptide synthesis conditions, while the aromatic sulfonyl protection supports controlled deprotection strategies for later guanidine unmasking. The combination of orthogonal protecting groups and an activated ester makes Fmoc-Arg(Mtr)-OPfp suitable as a research-grade intermediate for constructing arginine-rich sequences, including peptide analogs and guanidinium-containing linkers used in chemical biology and process-oriented peptide manufacturing.

1. Peptide Coupling Reagents

Fmoc-Arg(Mtr)-OPfp is applied in peptide synthesis workflows where activated carboxylate chemistry supports efficient amide bond formation for introducing arginine residues into growing chains. The Fmoc group enables orthogonal N-terminal protection during stepwise solid-phase or solution-phase assembly, while the OPfp ester provides a pentafluorophenyl-activated handle that can be converted into the corresponding peptide bond under standard coupling conditions. The Mtr-protected guanidinium side chain helps maintain compatibility with peptide coupling and purification steps by limiting nucleophilicity and minimizing side reactions such as guanidinium-mediated acyl transfer. The resulting arginine incorporation supports downstream deprotection to regenerate the free guanidinium functionality needed for salt-bridge formation, receptor binding studies, and charge-driven molecular recognition in peptide science.

2. Protected Arginine Building Blocks

Fmoc-Arg(Mtr)-OPfp is utilized as a protected amino acid derivative for preparing guanidinium-bearing peptide segments with controlled side-chain unmasking. The orthogonality between Fmoc (base-labile) and Mtr (typically removed under conditions compatible with peptide side-chain deprotection logic) supports iterative protection/deprotection cycles that preserve peptide integrity across multiple synthesis steps. The OPfp carboxylate activation allows the arginine residue to be introduced as a defined coupling unit rather than relying on less activated carboxylic acid derivatives, which can improve reproducibility in protected amino acid synthesis. The compound thus functions as a chiral arginine intermediate for constructing sequence-defined peptides, peptidomimetics, and charged linkers used to probe structure-activity relationships and molecular recognition mechanisms.

3. Chemical Biology Conjugation Handles

Fmoc-Arg(Mtr)-OPfp is suitable for chemical biology applications that require incorporation of arginine-derived guanidinium motifs into functional peptides and labeling scaffolds. The protected guanidinium group enables controlled synthesis of arginine-rich conjugation partners without premature side-chain reactivity, while the activated OPfp ester supports formation of amide-linked constructs that can later be converted into free cationic guanidinium for binding to nucleic acids, proteins, or cell-surface targets. The Fmoc-protected backbone can be leveraged to generate peptide fragments with defined N-terminus handling, supporting subsequent conjugation steps such as coupling to targeting ligands, affinity tags, or reporter-bearing moieties. Downstream, deprotected arginine residues can enhance electrostatic interactions in biomolecule labeling and chemical probe design, aligning with amino acid chemistry strategies for building charge-mediated recognition elements.

4. Peptidomimetics And SAR Studies

Fmoc-Arg(Mtr)-OPfp is employed in peptidomimetic construction and structure-activity relationship studies where guanidinium-containing residues are used to tune binding affinity, permeability proxies, and receptor selectivity patterns. The stereochemically defined arginine backbone supports insertion of a chiral, charge-bearing motif into analog libraries, while the Mtr protection helps maintain side-chain integrity during synthesis of analogs that may include additional functional groups. The OPfp ester activation supports rapid diversification of peptide analogs by enabling consistent coupling of the arginine unit across a set of structurally related scaffolds. The resulting arginine-containing peptidomimetics can serve as defined chemical entities for SAR mapping, fragment-based optimization, and mechanistic studies focused on how cationic side chains contribute to binding and conformational preferences in peptide science.

5. Pharmaceutical Intermediate Preparation

Fmoc-Arg(Mtr)-OPfp is relevant to pharmaceutical manufacturing and fine chemical synthesis contexts where protected amino acid derivatives are used as controlled intermediates for producing peptide-based active ingredients or peptide intermediates. The Fmoc protection strategy supports standardized N-terminal handling during manufacturing-scale peptide assembly, while the Mtr-protected guanidinium side chain provides a predictable protection profile that can be aligned with established deprotection and purification sequences. The OPfp ester functionality is compatible with industrially scalable coupling approaches that rely on activated carboxylates to form amide bonds with minimized byproduct formation from unactivated acids. The compound can therefore be incorporated into process chemistry routes for producing arginine-containing peptide intermediates, including sequence-defined fragments used in downstream API synthesis, analytical reference standards, and formulation-enabling peptide materials.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry